Clinical Trial Update: Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on induction pembrolizumab with chemotherapy and subsequent pembrolizumab before chemoradiation with maintenance, compared to standard chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma
• Stage Iiia Cervical Cancer
• Stage Iiib Cervical Cancer
• Stage Iiic1 Cervical Cancer
• Stage Iiic2 Cervical Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma | Phase 3 | Status: RECRUITING